Basilea Pharmaceutica AG
BPMUF
$67.75
$6.4110.45%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 83.61M | 85.49M | 88.56M | 44.11M | -861.60K |
| Total Depreciation and Amortization | 3.88M | 3.76M | 3.69M | 3.69M | 3.67M |
| Total Amortization of Deferred Charges | 1.04M | 1.01M | 1.02M | 1.34M | 1.65M |
| Total Other Non-Cash Items | 3.61M | -5.98M | -15.44M | -12.85M | -10.23M |
| Change in Net Operating Assets | -570.30K | 3.21M | 7.08M | 12.19M | 17.31M |
| Cash from Operations | 91.56M | 87.50M | 84.92M | 48.48M | 11.54M |
| Capital Expenditure | -1.80M | -1.86M | -1.95M | -1.53M | -1.09M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 0.00 | 431.80K | 878.40K | 878.40K | 878.40K |
| Other Investing Activities | -141.40K | -114.30K | -92.90K | -158.80K | -224.70K |
| Cash from Investing | -1.94M | -1.55M | -1.17M | -805.90K | -435.70K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | -7.80M | -15.60M | -36.05M | -56.49M |
| Issuance of Common Stock | 654.00K | 1.56M | 2.46M | 2.91M | 3.36M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -15.15M | -7.58M | -21.00K | -128.50K | -236.00K |
| Cash from Financing | -16.84M | -15.34M | -14.81M | -37.51M | -60.26M |
| Foreign Exchange rate Adjustments | -80.50K | -13.50K | 54.90K | 10.00K | -34.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -600.00 | -1.20K |
| Net Change in Cash | 72.70M | 70.60M | 69.00M | 10.18M | -49.20M |